Clinical Trials
3 trialsNCT03826589 2025-06-11
ALARICE
The University of Hong Kong
Phase NA Completed
NCT00828919 2024-12-03
Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials
Pfizer
Phase NA Completed
NCT01486251 2016-02-10
AXUS
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Completed